USANA Health Sciences (USNA) Stock Price
USANA Health Sciences Price
Revenue has compounded at 4.9% per year over the past 19 years to 925.26 M USD. Earnings per share have declined at 3.3% per year over the last 19 years. USANA Health Sciences's net margin stands at 1.2%, down from 9.8% several years earlier. Analysts set a median price target of 51.51 USD, implying 260.0% above the current price. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.
USANA Health Sciences stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
USANA Health Sciences business model & stock analysis
Frequently asked questions about USANA Health Sciences
USANA Health Sciences Inc operates through a direct selling business model. The company manufactures and distributes science-based nutritional and personal care products. USANA's business model involves independent associates who sell its products directly to customers, earning commissions and bonuses based on their sales and the sales of their team. This model allows USANA to bypass traditional retail channels and establish a strong relationship with its customers. With a focus on health and wellness, USANA Health Sciences Inc aims to provide high-quality products that promote a healthy lifestyle and support optimal well-being.
USANA Health Sciences Inc is primarily active in the healthcare and wellness industry.
The main competitors of USANA Health Sciences Inc in the market include Herbalife Nutrition Ltd, Nu Skin Enterprises Inc, and Shaklee Corporation.
USANA Health Sciences Inc is a renowned healthcare organization that specializes in manufacturing and distributing nutritional and personal care products. Established in 1992, USANA Health Sciences has grown into a prominent player in the industry. The company's commitment to scientific research and innovative product development has earned it a stellar reputation among health-conscious consumers. USANA Health Sciences has a global presence and operates with a direct-selling business model, allowing individuals to become independent business owners by selling their top-quality products. With a strong emphasis on delivering health and wellness solutions, USANA Health Sciences continues to make a positive impact on people's lives worldwide.
USANA Health Sciences Inc has achieved several significant milestones throughout its history. The company has consistently delivered strong financial performance, with a track record of revenue growth and profitability. USANA has received numerous awards and recognition for its exceptional products and business model, including being ranked among the top direct selling companies worldwide. The company has expanded its global presence, successfully entering new markets and establishing a strong international footprint. USANA has also invested in cutting-edge scientific research and development, continuously innovating its product offerings to provide the highest quality nutritional supplements. With a dedicated team and a commitment to health and wellness, USANA Health Sciences Inc continues to thrive in the industry.
USANA Health Sciences Inc is primarily present in various countries and regions around the world. The multinational company operates in over 20 markets, including the United States, Canada, Mexico, Australia, New Zealand, Hong Kong, Taiwan, South Korea, Japan, Singapore, Malaysia, Thailand, the Netherlands, United Kingdom, France, Belgium, Colombia, Philippines, Germany, Spain, and Italy. With its extensive global presence, USANA Health Sciences Inc caters to a diverse range of customers, providing high-quality nutritional products, personal care items, and weight-management solutions across these regions.
USANA Health Sciences Inc represents a dedication to health and well-being through their products and business practices. The company's corporate philosophy centers around their commitment to deeply scientific research and the pursuit of excellence. USANA's values include integrity, innovation, and a focus on people, reflected in their high-quality nutritional supplements and personal care products. With a mission to develop and provide the highest quality science-based health products, USANA Health Sciences Inc aims to empower individuals to take control of their own health and live their best lives.
Analysts currently set an average price target of 51.51 USD for the USANA Health Sciences stock (median: 51.51 USD), implying +260.0 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the USANA Health Sciences stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect USANA Health Sciences to generate revenue of 909.00 M USD and earnings per share of 0.77 USD.
Converted at the current exchange rate, the USANA Health Sciences share trades at 12.78 EUR (14.31 USD).
The USANA Health Sciences share (USNA) is listed on 4 stock exchanges, including: NYSE (USNA), SIX (Zürich) (USJ.SW), Frankfurt (USJ.F), München (USJ.MU).
USANA Health Sciences, Inc. is a multinational company specializing in the production and distribution of dietary supplements, personalized health products, and skincare products. It was founded in 1992 and operates in over 20 countries worldwide. USANA operates on a multi-level marketing system, rewarding associates for selling products and recruiting new distributors. The company offers a variety of products including supplements, personalized health products, and skincare products. USANA prides itself on using high-quality ingredients and manufacturing products in safe facilities. They invest in research and development and marketing activities to support business growth and the success of their distributors.
The expected revenue of USANA Health Sciences is 909.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of USANA Health Sciences is 14.12 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of USANA Health Sciences is currently 18.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the USANA Health Sciences stock.
The price-to-sales ratio (P/S) of USANA Health Sciences is currently 0.29. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the USANA Health Sciences stock.
The Eulerpool Quality Score for USANA Health Sciences is 2/10.
The ISIN of USANA Health Sciences is US90328M1071. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of USANA Health Sciences is 923145. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of USANA Health Sciences is USNA. The ticker symbol is used to trade USANA Health Sciences shares on the stock exchange.
USANA Health Sciences stock
USANA Health Sciences Peer Group
USANA Health Sciences Ticker
USANA Health Sciences FIGI
All fundamentals and in-depth analysis of USANA Health Sciences
Our stock analysis for USANA Health Sciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.